Cochrane Database of Systematic Reviews 2012
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Abstract: Use of procalcitonin to guide initiation and duration of antibiotic treatment in patients with ARI was not associated with higher mortality rates or treatment failure. Antibiotic consumption was significantly reduced across different clinical settings and ARI diagnoses. Further high-quality research is needed to confirm the safety of this approach for non-European countries and patients in intensive care. Moreover, future studies should also establish cost-effectiveness by considering country-specific costs of…
Search citation statements
Paper Sections
Select...
279
39
37
5
Citation Types
5
195
1
9
Year Published
Range
2012
2026
Publication Types
Select...
297
27
15
9
Relationship
13
335
Authors
Journals
Cited by 348 publications
(210 citation statements)
References 58 publications
5
195
1
9
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In both the chi squared analysis and logistic regression analyses ordering a procalcitonin test was not associated with number of antibiotics used, duration of antibiotic use and type of diagnosis (SEPSIS or COPD). This finding differs from some studies that showed that procalcitonin reduced the number and duration of antibiotics use [26][27][28][29][30][31][32] . However, similar to our finding, a few studies did not show a difference in antibiotics use in procalcitonin guided therapy [33] .…”
Section: Discussion
contrasting
confidence: 99%